The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Cisplatin Induces Pyroptosis via Activation of MEG3/NLRP3/caspase-1/GSDMD Pathway in Triple-Negative Breast Cancer
Open accessAbstract
Cisplatin (DDP) was reported to improve pathological complete response (pCR) rates in triple-negative breast cancer (TNBC) patients, however, the molecular mechanism still remains largely unknown.Emerging evidence suggested that some chemotherapeutic drugs played anti-tumor effects by inducing cell pyroptosis.Nevertheless, whether pyroptosis contributes to the DDP-induced anti-tumor effect in TNBC remains unexploited.In the present study, NLRP3/caspase-1/GSDMD pyroptosis pathway was involved in the DDP-induced anti-tumor effect of TNBC in vitro and in vivo, providing evidence that DDP might induce pyroptosis in TNBC.Moreover, DDP activated NLRP3/caspase-1/GSDMD pyroptosis pathway by up-regulating the long non-coding RNA (lncRNA) maternally expressed gene 3 (MEG3).Furthermore, knockdown of MEG3 not only partly abolished the activation effect of DDP on NLRP3/caspase-1/GSDMD pathway-mediated pyroptosis, but also reversed the suppression of DDP on tumor growth and metastasis ability in vitro and in vivo, further confirming that MEG3 may partially mediate the pyroptotic signaling upon DDP treatment.Thus, our data uncovered a novel mechanism that DDP induced pyroptosis via activation of MEG3/NLRP3/caspase-1/GSDMD pathway in TNBC to exert anti-tumor effects, which may help to develop new strategies for the therapeutic interventions in TNBC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Self-citationCleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., Zhuang, Y., Cai, T., Wang, F., & Shao, F. (2015) · Nature · doi:10.1038/nature15514 · Cited by 6,659
Functional Classification and Experimental Dissection of Long Noncoding RNAs
Kopp, F., & Mendell, J. T. (2018) · Cell · doi:10.1016/j.cell.2018.01.011 · Cited by 3,529
Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin
Wang, Y., Gao, W., Shi, X., Ding, J., Liu, W., He, H., Wang, K., & Shao, F. (2017) · Nature · doi:10.1038/nature22393 · Cited by 3,199
Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion
He, W.-T., Wan, H., Hu, L., Chen, P., Wang, X., Huang, Z., Yang, Z.-H., Zhong, C.-Q., & Han, J. (2015) · Cell Research · doi:10.1038/cr.2015.139 · Cited by 2,517
Mechanisms and Functions of Inflammasomes
Lamkanfi, M., & Dixit, V. M. (2014) · Cell · doi:10.1016/j.cell.2014.04.007 · Cited by 2,503
GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death
Sborgi, L., Rühl, S., Mulvihill, E., Pipercevic, J., Heilig, R., Stahlberg, H., Farady, C. J., Müller, D. J., Broz, P., & Hiller, S. (2016) · The EMBO Journal · doi:10.15252/embj.201694696 · Cited by 1,152
The Pore-Forming Protein Gasdermin D Regulates Interleukin-1 Secretion from Living Macrophages
Evavold, C. L., Ruan, J., Tan, Y., Xia, S., Wu, H., & Kagan, J. C. (2018) · Immunity · doi:10.1016/j.immuni.2017.11.013 · Cited by 1,115
Broad targeting of resistance to apoptosis in cancer
Mohammad, R. M., Muqbil, I., Lowe, L., Yedjou, C., Hsu, H.-Y., Lin, L.-T., Siegelin, M. D., Fimognari, C., Kumar, N. B., Dou, Q. P., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.001 · Cited by 864
Converging roles of caspases in inflammasome activation, cell death and innate immunity
Man, S. M., & Kanneganti, T.-D. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.7 · Cited by 701
Lin, N. U., Vanderplas, A., Hughes, M. E., Theriault, R. L., Edge, S. B., Wong, Y., Blayney, D. W., Niland, J. C., Winer, E. P., & Weeks, J. C. (2012) · Cancer · doi:10.1002/cncr.27581 · Cited by 695
Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis
Wu, X., Zhang, H., Qi, W., Zhang, Y., Li, J., Li, Z., Lin, Y., Bai, X., Liu, X., Chen, X., et al. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0257-3 · Cited by 586
Self-citationThe lncRNA Neat1 promotes activation of inflammasomes in macrophages
Zhang, P., Cao, L., Zhou, R., Yang, X., & Wu, M. (2019) · Nature Communications · doi:10.1038/s41467-019-09482-6 · Cited by 499
Poggio, F., Bruzzone, M., Ceppi, M., Pondé, N. F., La Valle, G., Del Mastro, L., de Azambuja, E., & Lambertini, M. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy127 · Cited by 468
The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease
Wang, S., Yuan, Y.-H., Chen, N.-H., & Wang, H.-B. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2018.12.019 · Cited by 444
Zhang, C.-C., Li, C.-G., Wang, Y.-F., Xu, L.-H., He, X.-H., Zeng, Q.-Z., Zeng, C.-Y., Mai, F.-Y., Hu, B., & Ouyang, D.-Y. (2019) · Apoptosis · doi:10.1007/s10495-019-01515-1 · Cited by 442
Zhang, Y., Liu, X., Bai, X., Lin, Y., Li, Z., Fu, J., Li, M., Zhao, T., Yang, H., Xu, R., et al. (2018) · Journal of Pineal Research · doi:10.1111/jpi.12449 · Cited by 399
Chen, X., Liu, G., Yuan, Y., Wu, G., Wang, S., & Yuan, L. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-2157-1 · Cited by 388
Mitochondrial ROS promote macrophage pyroptosis by inducing GSDMD oxidation
Wang, Y., Shi, P., Chen, Q., Huang, Z., Zou, D., Zhang, J., Gao, X., & Lin, Z. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz020 · Cited by 362
Hu, L., Chen, M., Chen, X., Zhao, C., Fang, Z., Wang, H., & Dai, H. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2476-2 · Cited by 319
GSDME mediates caspase-3-dependent pyroptosis in gastric cancer
Wang, Y., Yin, B., Li, D., Wang, G., Han, X., & Sun, X. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.11.156 · Cited by 299
Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy
Yang, F., Qin, Y., Lv, J., Wang, Y., Che, H., Chen, X., Jiang, Y., Li, A., Sun, X., Yue, E., et al. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-1029-4 · Cited by 273
Triple-negative breast cancer: recent treatment advances
Bergin, A. R. T., & Loi, S. (2019) · F1000Research · doi:10.12688/f1000research.18888.1 · Cited by 248
Wu, M., Wang, Y., Yang, D., Gong, Y., Rao, F., Liu, R., Danna, Y., Li, J., Fan, J., Chen, J., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.02.012 · Cited by 240
Russo, H. M., Rathkey, J., Boyd-Tressler, A., Katsnelson, M. A., Abbott, D. W., & Dubyak, G. R. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600699 · Cited by 193
Yan, H., Rao, J., Yuan, J., Gao, L., Huang, W., Zhao, L., & Ren, J. (2017) · Cell Death & Disease · doi:10.1038/s41419-017-0047-y · Cited by 190
Self-citationNeoadjuvant Treatment for Triple Negative Breast Cancer: Recent Progresses and Challenges
Lee, J. S., Yost, S. E., & Yuan, Y. (2020) · Cancers · doi:10.3390/cancers12061404 · Cited by 178
Liang, J., Wang, Q., Li, J.-Q., Guo, T., & Yu, D. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113139 · Cited by 170
LncRNA KCNQ1OT1 Mediates Pyroptosis in Diabetic Cardiomyopathy
Yang, F., Qin, Y., Wang, Y., Li, A., Lv, J., Sun, X., Che, H., Han, T., Meng, S., Bai, Y., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000494576 · Cited by 166
Chaudhary, L. N., Wilkinson, K. H., & Kong, A. L. (2017) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2017.08.004 · Cited by 162
Rethinking neoadjuvant chemotherapy for breast cancer
Vaidya, J. S., Massarut, S., Vaidya, H. J., Alexander, E. C., Richards, T., Caris, J. A., Sirohi, B., & Tobias, J. S. (2018) · BMJ · doi:10.1136/bmj.j5913 · Cited by 109
GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death
Sborgi, L., Rühl, S., Mulvihill, E., Pipercevic, J., Heilig, R., Stahlberg, H., Farady, C. J., Müller, D. J., Brož, P., & Hiller, S. (2016) · edoc (University of Basel) · doi:10.5451/unibas-ep43749 · Cited by 82
Hu, J., Wu, H., Wang, D., Yang, Z., & Dong, J. (2018) · Biochimie · doi:10.1016/j.biochi.2018.10.011 · Cited by 81
Xu, X., Zhou, X., Chen, Z., Gao, C., Zhao, L. S., & Cui, Y. (2020) · Aging · doi:10.18632/aging.102673 · Cited by 79
Self-citation
Cited by
Role of pyroptosis in inflammation and cancer
Wei, X., Xie, F., Zhou, X., Wu, Y., Yan, H., Liu, T., Huang, J., Wang, F., Zhou, F., & Zhang, L. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-022-00905-x · Cited by 699
Self-citationPyroptosis in health and disease: mechanisms, regulation and clinical perspective
Liu, Y., Pan, R., Ouyang, Y., Gu, W., Xiao, T., Yang, H., Tang, L., Wang, H., Xiang, B., & Chen, P. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01958-2 · Cited by 337
Metadata
- Authors
- Yan, H., Luo, B., Wu, X., Guan, F., Yu, X., Zhao, L., Ke, X., Wu, J., & Yuan, J.
- Venue
- International Journal of Biological Sciences
- Publisher
- Ivyspring International Publisher
- Published
- 2021
- Volume
- 17
- Issue
- 10
- Pages
- 2606-2621
- ISSN
- 1449-2288 (ISSN-L)
- OpenAlex
- W3183286210
- Cited by
- 303
- References
- 34
- FWCI
- 12.95
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.